Cancers | Free Full-Text | Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States
Clinical Characteristics and Prognostic Factors of Early-Onset Pancreatic Neuroendocrine Tumors - Min Shi, Biao Zhou, 2021
![PDF] Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/dbefbcff3d1adac4d9382c85f93ecfd16024f5f9/3-Figure1-1.png "PDF] Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study. | Semantic Scholar")
PDF] Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study. | Semantic Scholar
Kaplan–Meier analyses of overall survival. (a) Overall survival in... | Download Scientific Diagram
Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations
Pancreatic neuroendocrine tumor - Wikipedia
Survival curves in patients with pancreatic neuroendocrine tumors... | Download Scientific Diagram
Frontiers | Consideration of Age Is Necessary for Increasing the Accuracy of the AJCC TNM Staging System of Pancreatic Neuroendocrine Tumors
Surufatinib promotes improved survival in advanced pancreatic neuroendocrine tumor - Onco Americas
Neuroendocrine Tumors - Cancer Therapy Advisor
Survivals of pancreatic neuroendocrine tumors with different grade by... | Download Scientific Diagram
Survival curves in different surgical status subgroup patients with... | Download Scientific Diagram
Pathophysiology and Treatment of Pancreatic Neuroendocrine Neoplasms (PNENS): New Developments - Endotext - NCBI Bookshelf
Prognosis of Patients with Neuroendocrine Neoplasms of the Pancre
Sex-Based Clinicopathologic and Survival Differences Among Patients with Pancreatic Neuroendocrine Tumors | SpringerLink
C-reactive protein independently predicts survival in pancreatic neuroendocrine neoplasms | Scientific Reports
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study | Journal of Clinical Oncology
Making Sense of a Complex Disease: A Practical Approach to Managing Neuroendocrine Tumors | JCO Oncology Practice
Cancers | Free Full-Text | Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know
Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma | AJR
